In these mice, SREBP1 was not up-regulated, indicating that de novo lipogenesis was not the driving factor of hepatic steatosis but rather an increase in saturated fatty acid uptake, which was found to induce hepatic inflammation and elevate LDL concentrations [283]. Here, SREBF1 is linked to fatty liver disease.